Using the Goal Attainment Scale adapted for depression to better understand treatment outcomes in patients with major depressive disorder switching to vortioxetine: a phase 4, single-arm, open-label, multicenter study

Abstract Background Major depressive disorder (MDD) is the leading cause of disability worldwide. Response to pharmacologic treatment is generally evaluated by traditional clinician- and patient-reported rating scales. Assessing therapeutic efficacy using the Goal Attainment Scale offers a complemen...

Descrición completa

Detalles Bibliográficos

Principais autores:	Maggie McCue, Sara Sarkey, Anna Eramo, Clement François, Sagar V. Parikh
Formato:	Artigo
Idioma:	Inglês
Publicado:	BMC 2021-12-01
Series:	BMC Psychiatry
Assuntos:	Major depressive disorder Vortioxetine Goal attainment Goal achievement
Acceso en liña:	https://doi.org/10.1186/s12888-021-03608-1
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!